Financhill
Back

Apellis Pharmaceuticals Stock Price Chart

New AI Stock Payouts

Watch this presentation before then!
Sell
50

APLS
Apellis Pharmaceuticals

Last Price:
63.88
Seasonality Move:
16.07%

7 Day Trial

ALL ACCESS PASS

$ 7

The "Scaled Selling Technique"

Click here for more details...
  • The current trend is moderately bearish and APLS is experiencing slight buying pressure.

Apellis Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 66.75 Sell
20-day SMA: 67.05 Sell
50-day SMA: 64.9 Sell
200-day SMA: 57.84 Buy
8-day EMA: 66.81 Sell
20-day EMA: 65.8 Sell
50-day EMA: 62.28 Buy
200-day EMA: 57.53 Buy

Apellis Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.29 Buy
Relative Strength Index (14 RSI): 45.34 Sell
Chaikin Money Flow: 279238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.04 - 68.9) Sell
Bollinger Bands (100): (48.93 - 66.57) Buy

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Apellis Pharmaceuticals Stock

Is Apellis Pharmaceuticals Stock a Buy?

APLS Technical Analysis vs Fundamental Analysis

Sell
50
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy or a Sell?

Apellis Pharmaceuticals Stock Info

Market Cap:
7.7B
Price in USD:
63.86
Share Volume:
2.56M

Apellis Pharmaceuticals 52-Week Range

52-Week High:
94.75
52-Week Low:
19.83
Sell
50
Apellis Pharmaceuticals (APLS) is a Sell

Apellis Pharmaceuticals Share Price Forecast

Is Apellis Pharmaceuticals Stock a Buy?

Fundamental Analysis of Apellis Pharmaceuticals

Is Apellis Pharmaceuticals a good investment?

  • Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.42 per share, an increase this year of $3.54 per share, and an increase next year of $2.18 per share.

Technical Analysis of Apellis Pharmaceuticals

Should I short Apellis Pharmaceuticals stock?

* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.